Verily co-founder lays out vision for how real-world data can transform health care – STAT


Biotech & Pharma
Health Tech
Business & Policy
Health & Science
Team
Exclusive analysis of biotech, pharma, and the life sciences
Topics
Columns
Tools
Events
Team
Account
More
Follow Us
In-depth analysis of biotech, pharma, and the life sciences
from some of the nation’s most trusted and well-connected reporters in the industry
with STAT+ reporters and leading industry experts in our STAT+ Conversations series
hosted by STAT+, plus early-bird access and discounts to industry events around the country
get delivered to your inbox to brief you on the most important industry news of the day
like our CRISPR Trackr and Drug Pricing Policy Tracker
In-depth analysis of biotech, pharma, and the life sciences
from some of the nation’s most trusted and well-connected reporters in the industry
with STAT+ reporters and leading industry experts in our STAT+ Conversations series
hosted by STAT+, plus early-bird access and discounts to industry events around the country
get delivered to your inbox to brief you on the most important industry news of the day
like our CRISPR Trackr and Drug Pricing Policy Tracker
By Jonathan Wosen June 16, 2022
SAN DIEGO — The real world’s a messy place, but there’s a lot you can learn out there.
If you want to be confident a treatment works, your best bet remains a randomized control trial. But such studies are often picky about the participants they’ll enroll. And these trials generally focus on just a few clinical measurements taken at a handful of time points.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
West Coast Biotech & Life Sciences Reporter
Jonathan Wosen is STAT’s West Coast Biotech & Life Sciences Reporter




This name will appear with your comment
There was an error saving your display name. Please check and try again.
By Mario Aguilar and Mohana Ravindranath
By Todd Feathers, Simon Fondrie-Teitler, Angie Waller, and Surya Mattu — The Markup
advertisement
By Ed Silverman
By Rachel Cohrs
By Bob Herman
Reporting from the frontiers of health and medicine
Subscribe to STAT+ for $15 per month lorem ipsum. Subscribe now
Join our community of lorem ipsum dolor sit amet sed do magna lorem ipsum.

source


Leave a Reply

Your email address will not be published.